Manhattan Associates (MANH) Financials

Manhattan Associates logo
$257.93 +0.78 (+0.30%)
Closing price 11/16/2026 04:00 PM Eastern
Extended Trading
$259.20 +1.27 (+0.49%)
As of 11/16/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Manhattan Associates

Annual Income Statements for Manhattan Associates

This table shows Manhattan Associates' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
103 124 116 105 86 87 110 129 177 218 220
Consolidated Net Income / (Loss)
103 124 116 105 86 87 110 129 177 218 220
Net Income / (Loss) Continuing Operations
103 124 116 105 86 87 110 129 177 218 220
Total Pre-Tax Income
163 196 185 136 116 114 134 158 214 267 286
Total Operating Income
161 194 186 134 116 114 134 153 210 262 280
Total Gross Profit
321 355 349 318 333 586 366 409 498 571 609
Total Revenue
556 605 595 559 618 586 664 767 929 1,042 1,081
Operating Revenue
556 605 595 559 618 586 664 767 929 1,042 1,081
Total Cost of Revenue
235 250 246 241 285 0.00 298 358 431 471 472
Operating Cost of Revenue
235 250 246 241 285 - 298 358 431 471 472
Total Operating Expenses
159 160 163 184 217 472 231 256 288 310 329
Selling, General & Admin Expense
49 48 46 - 65 61 68 73 81 90 94
Marketing Expense
49 48 47 51 57 48 58 65 74 76 81
Research & Development Expense
54 55 58 72 88 84 98 112 127 138 145
Depreciation Expense
7.76 9.09 9.06 8.61 7.99 8.95 7.91 6.66 5.75 6.30 6.32
Restructuring Charge
- - 2.92 - - - - - 0.00 0.00 2.94
Total Other Income / (Expense), net
1.40 1.80 -0.81 2.34 0.15 -0.29 -0.26 5.42 3.79 5.22 6.09
Interest Expense
-1.33 -1.16 -1.17 -1.07 -0.72 -0.10 -0.07 -0.60 -5.30 -6.03 -4.39
Other Income / (Expense), net
0.06 0.64 -1.99 1.28 -0.56 -0.38 -0.33 4.83 -1.51 -0.81 1.71
Income Tax Expense
59 72 68 32 30 27 24 29 37 48 66
Basic Earnings per Share
$1.41 $1.73 $1.68 $1.58 $1.33 $1.37 $1.74 $2.05 $2.86 $3.56 $3.64
Weighted Average Basic Shares Outstanding
73.44M 71.67M 69.18M 66.20M 64.40M 63.54M 63.45M 62.77M 61.82M 61.30M 60.47M
Diluted Earnings per Share
$1.40 $1.72 $1.68 $1.58 $1.32 $1.36 $1.72 $2.03 $2.82 $3.51 $3.60
Weighted Average Diluted Shares Outstanding
74.04M 72.06M 69.42M 66.43M 65.10M 64.33M 64.32M 63.41M 62.61M 62.18M 61.05M
Weighted Average Basic & Diluted Shares Outstanding
73.40M 71.80M 69.30M 66.30M 63.77M 63.80M 63.15M 62.50M - 61.12M 59.85M

Quarterly Income Statements for Manhattan Associates

This table shows Manhattan Associates' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Total Costs & Expenses
- - - - - - 200 - - - 225
Net Income / (Loss) Attributable to Common Shareholders
54 53 64 48 53 57 59 52 49 50 61
Consolidated Net Income / (Loss)
54 53 64 48 53 57 59 52 49 50 61
Net Income / (Loss) Continuing Operations
54 53 64 48 53 57 59 52 49 50 61
Total Pre-Tax Income
59 69 76 63 65 75 78 68 69 67 83
Total Operating Income
58 68 75 61 63 74 76 67 65 66 81
Total Gross Profit
135 145 267 24 148 156 156 149 156 168 174
Total Revenue
255 265 267 256 263 272 276 270 282 298 306
Operating Revenue
255 265 267 256 263 272 276 270 282 298 306
Total Cost of Revenue
119 120 0.00 232 115 116 120 122 127 129 132
Operating Cost of Revenue
119 120 - - 115 116 120 122 127 129 132
Total Operating Expenses
78 77 192 -37 85 82 80 82 91 102 93
Selling, General & Admin Expense
21 21 20 27 24 26 24 19 24 27 29
Marketing Expense
20 19 17 20 21 20 18 22 28 31 27
Research & Development Expense
35 35 34 33 35 35 36 39 37 35 36
Depreciation Expense
1.49 1.49 1.69 1.63 1.54 1.58 1.66 1.53 1.83 1.63 1.72
Restructuring Charge
0.00 0.00 0.00 - 2.93 0.01 0.00 - 0.00 8.26 0.00
Total Other Income / (Expense), net
1.00 0.91 1.31 2.00 1.34 0.72 2.60 1.44 4.34 0.98 1.89
Other Income / (Expense), net
1.00 0.91 1.31 -4.03 1.34 0.72 2.60 -2.95 4.34 0.98 1.89
Income Tax Expense
4.83 16 13 15 12 18 20 16 20 17 22
Basic Earnings per Share
$0.87 $0.86 $1.04 $0.79 $0.86 $0.94 $0.97 $0.87 $0.83 $0.86 $1.05
Weighted Average Basic Shares Outstanding
61.63M 61.42M 61.17M 61.30M 60.87M 60.61M 60.38M 60.47M 59.69M 58.76M 58.21M
Diluted Earnings per Share
$0.86 $0.85 $1.03 $0.77 $0.85 $0.93 $0.96 $0.86 $0.82 $0.85 $1.04
Weighted Average Diluted Shares Outstanding
62.49M 62.12M 61.95M 62.18M 61.53M 61.07M 60.95M 61.05M 60.04M 59.00M 58.73M
Weighted Average Basic & Diluted Shares Outstanding
61.57M 61.25M 61.08M 61.12M 60.71M 60.47M 60.26M 59.85M 59.16M 58.30M 58.06M

Annual Cash Flow Statements for Manhattan Associates

This table details how cash moves in and out of Manhattan Associates' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
2.71 -23 27 -22 12 94 59 -38 45 -4.51 63
Net Cash From Operating Activities
120 139 164 137 147 141 185 180 246 295 389
Net Cash From Continuing Operating Activities
120 139 164 137 147 141 185 180 246 295 389
Net Income / (Loss) Continuing Operations
103 124 116 105 86 87 110 129 177 218 220
Consolidated Net Income / (Loss)
103 124 116 105 86 87 110 129 177 218 220
Depreciation Expense
7.76 9.09 9.06 8.61 7.99 8.95 7.91 6.66 5.75 6.30 6.32
Non-Cash Adjustments To Reconcile Net Income
15 11 30 20 31 52 83 58 73 93 111
Changes in Operating Assets and Liabilities, net
-5.66 -5.39 8.90 3.83 22 -7.74 -17 -14 -9.01 -22 52
Net Cash From Investing Activities
-14 3.36 -5.77 -9.84 -14 -2.73 -4.02 -6.59 -4.73 -8.68 -15
Net Cash From Continuing Investing Activities
-14 3.36 -5.77 -9.84 -14 -2.73 -4.02 -6.59 -4.73 -8.68 -15
Purchase of Property, Plant & Equipment
-11 -6.84 -6.20 -7.31 -15 -2.73 -4.02 -6.59 -4.73 -8.68 -15
Purchase of Investments
-15 - -13 -15 - 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
-102 -163 -132 -149 -121 -44 -120 -204 -196 -286 -315
Net Cash From Continuing Financing Activities
-102 -163 -132 -149 -121 -44 -120 -204 -196 -286 -315
Repurchase of Common Equity
-112 -168 -132 -149 -121 -44 -120 -204 -196 -286 -315
Other Net Changes in Cash
- - - - - - - -6.83 -0.16 -4.47 3.67
Cash Income Taxes Paid
51 59 65 40 30 24 29 58 67 83 47

Quarterly Cash Flow Statements for Manhattan Associates

This table details how cash moves in and out of Manhattan Associates' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-63 -4.82 12 51 -60 25 33 65 -103 -40 13
Net Cash From Operating Activities
55 73 62 105 75 74 93 147 84 91 69
Net Cash From Continuing Operating Activities
55 73 62 105 75 74 93 147 84 91 69
Net Income / (Loss) Continuing Operations
54 53 64 48 53 57 59 52 49 50 61
Consolidated Net Income / (Loss)
54 53 64 48 53 57 59 52 49 50 61
Depreciation Expense
1.49 1.49 1.69 1.63 1.54 1.58 1.66 1.53 1.83 1.63 1.72
Non-Cash Adjustments To Reconcile Net Income
22 25 24 21 30 25 27 30 24 31 37
Changes in Operating Assets and Liabilities, net
-23 -5.78 -27 34 -8.37 -8.92 6.03 63 8.76 7.79 -31
Net Cash From Investing Activities
-2.32 -2.22 -1.01 -3.13 -0.89 -3.98 -5.93 -4.66 -4.10 -1.01 -0.99
Net Cash From Continuing Investing Activities
-2.32 -2.22 -1.01 -3.13 -0.89 -3.98 -5.93 -4.66 -4.10 -1.01 -0.99
Purchase of Property, Plant & Equipment
-2.32 -2.22 -1.01 -3.13 -0.89 -3.98 -5.93 -4.66 -4.10 -1.01 -0.99
Net Cash From Financing Activities
-114 -76 -52 -45 -136 -50 -52 -77 -179 -127 -50
Net Cash From Continuing Financing Activities
-114 -76 -52 -45 -136 -50 -52 -77 -179 -127 -50
Repurchase of Common Equity
-114 -76 -52 -45 -136 -50 -52 -77 -179 -127 -50
Other Net Changes in Cash
-1.80 -0.15 2.56 -5.08 1.72 4.84 -2.67 -0.23 -3.17 -2.61 -3.81

Annual Balance Sheets for Manhattan Associates

This table presents Manhattan Associates' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
332 297 315 307 372 465 540 570 673 758 839
Total Current Assets
237 207 228 215 232 334 408 415 479 503 583
Cash & Equivalents
118 96 126 99 111 205 264 225 271 266 329
Accounts Receivable
97 100 92 100 101 109 124 167 181 205 215
Prepaid Expenses
9.22 10 9.15 11 14 15 17 23 21 22 40
Plant, Property, & Equipment, net
21 17 15 14 23 18 14 13 12 14 23
Total Noncurrent Assets
74 73 71 77 118 113 117 142 182 240 233
Goodwill
62 62 62 62 62 62 62 62 62 62 62
Noncurrent Deferred & Refundable Income Taxes
4.65 2.87 1.88 5.44 6.81 5.76 7.65 37 66 95 76
Other Noncurrent Operating Assets
7.28 7.60 7.30 9.77 48 45 48 43 54 84 95
Total Liabilities & Shareholders' Equity
332 297 315 307 372 465 540 570 673 758 839
Total Liabilities
137 128 140 160 230 247 289 343 395 458 525
Total Current Liabilities
127 118 124 145 182 197 249 316 366 400 456
Accounts Payable
11 12 14 18 21 18 20 26 25 27 22
Accrued Expenses
14 13 12 12 19 21 23 25 27 22 27
Current Deferred Revenue
69 63 - - 94 - 153 209 238 278 337
Current Deferred & Payable Income Tax Liabilities
4.07 8.92 7.23 3.54 1.35 1.87 0.38 2.05 3.03 1.26 0.80
Current Employee Benefit Liabilities
29 21 16 29 46 42 53 54 73 72 69
Total Noncurrent Liabilities
9.57 10 16 15 48 50 40 28 29 58 69
Other Noncurrent Operating Liabilities
5.72 7.15 14 15 48 50 40 28 29 58 69
Total Equity & Noncontrolling Interests
195 169 175 147 142 219 251 227 278 299 315
Total Preferred & Common Equity
195 169 175 147 142 219 251 227 278 299 315
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
195 169 175 147 142 219 251 227 278 299 315
Common Stock
0.73 0.70 0.68 0.65 0.64 0.64 0.63 0.62 0.62 0.61 0.60
Retained Earnings
207 185 186 163 159 237 270 254 305 329 345
Accumulated Other Comprehensive Income / (Loss)
-12 -16 -12 -17 -18 -18 -20 -28 -27 -31 -31

Quarterly Balance Sheets for Manhattan Associates

This table presents Manhattan Associates' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
527 573 675 665 698 708 745 769 741 699 751
Total Current Assets
360 393 445 426 452 455 483 526 516 467 513
Cash & Equivalents
153 182 208 203 215 206 231 264 226 186 199
Accounts Receivable
178 183 206 191 200 211 210 220 227 219 268
Prepaid Expenses
28 27 32 32 38 39 43 43 63 62 45
Plant, Property, & Equipment, net
12 11 13 13 13 14 16 20 25 25 24
Total Noncurrent Assets
155 169 217 226 233 239 245 223 199 207 214
Goodwill
62 62 62 62 62 62 62 62 62 62 62
Noncurrent Deferred & Refundable Income Taxes
48 56 70 79 87 92 99 76 44 51 59
Other Noncurrent Operating Assets
45 51 85 85 84 85 84 84 93 94 93
Total Liabilities & Shareholders' Equity
527 573 675 665 698 708 745 769 741 699 751
Total Liabilities
356 363 435 425 420 463 466 460 535 541 550
Total Current Liabilities
331 333 372 363 362 405 407 400 467 475 480
Accounts Payable
26 25 26 26 23 24 24 21 22 31 22
Accrued Expenses
25 26 25 23 23 26 22 24 31 30 33
Current Deferred Revenue
227 213 264 259 253 297 300 296 356 343 348
Current Deferred & Payable Income Tax Liabilities
0.11 0.52 8.28 0.43 0.29 3.39 0.27 0.09 0.09 0.17 0.27
Current Employee Benefit Liabilities
52 67 49 55 63 55 61 59 58 71 77
Total Noncurrent Liabilities
26 30 63 62 58 58 59 59 68 66 70
Other Noncurrent Operating Liabilities
26 30 63 62 58 58 59 59 68 66 70
Total Equity & Noncontrolling Interests
171 210 240 241 278 245 279 309 205 158 201
Total Preferred & Common Equity
171 210 240 241 278 245 279 309 205 158 201
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
171 210 240 241 278 245 279 309 205 158 201
Common Stock
0.62 0.62 0.62 0.61 0.61 0.61 0.60 0.60 0.59 0.58 0.58
Retained Earnings
197 238 267 268 303 274 304 339 241 194 239
Accumulated Other Comprehensive Income / (Loss)
-27 -29 -28 -28 -26 -30 -26 -30 -36 -37 -38

Annual Metrics And Ratios for Manhattan Associates

This table displays calculated financial ratios and metrics derived from Manhattan Associates' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
13.06% 8.66% -1.65% -5.96% 10.51% -5.11% 13.18% 15.59% 21.07% 12.23% 3.75%
EBITDA Growth
27.17% 20.54% -5.55% -25.40% -14.21% -0.59% 15.73% 15.69% 30.41% 24.74% 7.76%
EBIT Growth
27.44% 20.70% -5.79% -26.40% -14.65% -1.46% 17.88% 17.55% 32.28% 25.16% 7.95%
NOPAT Growth
25.97% 19.99% -4.96% -12.06% -16.76% 2.11% 26.56% 12.51% 39.26% 23.44% 0.54%
Net Income Growth
26.19% 20.06% -6.24% -10.12% -18.08% 1.72% 26.63% 16.73% 36.92% 23.67% 0.73%
EPS Growth
29.63% 22.86% -2.33% -5.95% -16.46% 3.03% 26.47% 18.02% 38.92% 24.47% 2.56%
Operating Cash Flow Growth
27.60% 15.97% 17.74% -16.28% 6.96% -4.10% 31.44% -3.00% 37.07% 19.81% 32.02%
Free Cash Flow Firm Growth
28.91% 24.22% 21.74% -25.17% -4.83% 4.21% 31.54% -20.16% 51.84% 12.86% 38.89%
Invested Capital Growth
15.88% 10.52% -32.97% -5.77% -32.16% -55.09% -192.04% 110.24% 463.72% 336.46% -142.50%
Revenue Q/Q Growth
2.02% 1.03% -0.59% 0.05% 1.41% -0.99% 3.82% 3.59% 4.52% 0.00% 1.37%
EBITDA Q/Q Growth
6.34% 3.25% -1.47% -6.33% -6.01% 2.66% -0.68% 12.18% 4.64% 0.00% 2.60%
EBIT Q/Q Growth
6.40% 3.31% -1.50% -6.57% -6.61% 2.99% -0.45% 12.98% 4.77% 0.00% 2.70%
NOPAT Q/Q Growth
6.71% 2.84% -3.92% 1.47% -10.15% 4.94% -0.27% 15.12% 6.67% 0.00% 2.08%
Net Income Q/Q Growth
6.17% 2.94% -4.43% 1.36% -9.65% 4.53% 0.04% 15.48% 6.56% 0.00% 1.82%
EPS Q/Q Growth
5.26% 1.78% -2.89% 2.60% -9.59% 4.62% 0.00% 15.34% 7.22% 0.00% 2.56%
Operating Cash Flow Q/Q Growth
-3.48% 1.26% 6.20% -8.89% 0.36% 2.51% 1.14% 9.19% 15.55% 0.00% 12.20%
Free Cash Flow Firm Q/Q Growth
-4.54% 1.19% 5.98% -12.07% -2.37% 5.24% -1.84% 10.93% 23.09% 636.09% 14.86%
Invested Capital Q/Q Growth
-6.30% -3.22% -23.52% 1.75% -16.91% -34.67% -67.08% 23.91% -72.88% -47.78% -130.62%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
57.69% 58.67% 58.67% 56.92% 53.89% 100.00% 55.12% 53.30% 53.63% 54.82% 56.32%
EBITDA Margin
30.42% 33.75% 32.41% 25.71% 19.96% 20.91% 21.38% 21.40% 23.06% 25.62% 26.62%
Operating Margin
29.02% 32.14% 31.22% 23.94% 18.76% 19.45% 20.24% 19.91% 22.60% 25.10% 25.87%
EBIT Margin
29.03% 32.25% 30.89% 24.17% 18.67% 19.39% 20.19% 20.54% 22.44% 25.02% 26.03%
Profit (Net Income) Margin
18.60% 20.55% 19.59% 18.72% 13.88% 14.88% 16.65% 16.81% 19.01% 20.95% 20.34%
Tax Burden Percent
63.54% 63.35% 63.02% 76.85% 73.88% 76.68% 82.40% 81.56% 82.64% 81.84% 76.93%
Interest Burden Percent
100.82% 100.60% 100.64% 100.79% 100.62% 100.09% 100.05% 100.38% 102.55% 102.31% 101.56%
Effective Tax Rate
36.46% 36.65% 36.98% 23.15% 26.12% 23.32% 17.60% 18.44% 17.36% 18.16% 23.07%
Return on Invested Capital (ROIC)
165.04% 175.24% 189.95% 214.32% 219.10% 381.98% 19,590.63% 0.00% 3,908.86% 1,059.00% 2,276.19%
ROIC Less NNEP Spread (ROIC-NNEP)
164.34% 174.23% 190.41% 212.72% 219.00% 382.12% 19,590.72% 0.00% 3,907.60% 1,057.41% 2,274.62%
Return on Net Nonoperating Assets (RNNOA)
-110.22% -107.14% -122.29% -149.31% -159.84% -333.67% -19,543.57% 0.00% -3,838.94% -983.37% -2,204.54%
Return on Equity (ROE)
54.82% 68.10% 67.66% 65.00% 59.26% 48.31% 47.06% 54.02% 69.92% 75.64% 71.66%
Cash Return on Invested Capital (CROIC)
150.33% 165.25% 229.43% 220.26% 257.43% 458.01% 0.00% 8,237.76% 3,769.13% 933.57% 0.00%
Operating Return on Assets (OROA)
49.66% 61.95% 60.01% 43.45% 33.96% 27.14% 26.66% 28.39% 33.51% 36.45% 35.26%
Return on Assets (ROA)
31.82% 39.48% 38.06% 33.65% 25.25% 20.83% 21.98% 23.24% 28.40% 30.52% 27.55%
Return on Common Equity (ROCE)
54.82% 68.10% 67.66% 65.00% 59.26% 48.31% 47.06% 54.02% 69.92% 75.64% 71.66%
Return on Equity Simple (ROE_SIMPLE)
52.93% 73.35% 66.58% 71.15% 60.28% 39.85% 44.08% 56.86% 63.45% 73.00% 0.00%
Net Operating Profit after Tax (NOPAT)
103 123 117 103 86 87 111 125 173 214 215
NOPAT Margin
18.44% 20.36% 19.68% 18.40% 13.86% 14.92% 16.68% 16.24% 18.67% 20.54% 19.91%
Net Nonoperating Expense Percent (NNEP)
0.70% 1.02% -0.46% 1.59% 0.11% -0.14% -0.09% 1.81% 1.26% 1.59% 1.58%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 54.91% 62.32% 71.57% 68.39%
Cost of Revenue to Revenue
42.31% 41.33% 41.33% 43.08% 46.12% 0.00% 44.88% 46.70% 46.37% 45.18% 43.68%
SG&A Expenses to Revenue
8.85% 7.99% 7.75% 0.00% 10.45% 10.48% 10.26% 9.53% 8.74% 8.62% 8.67%
R&D to Revenue
9.68% 9.05% 9.70% 12.86% 14.18% 14.37% 14.71% 14.58% 13.65% 13.21% 13.41%
Operating Expenses to Revenue
28.67% 26.53% 27.45% 32.98% 35.13% 80.55% 34.88% 33.39% 31.04% 29.72% 30.45%
Earnings before Interest and Taxes (EBIT)
162 195 184 135 115 114 134 158 208 261 282
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
169 204 193 144 123 123 142 164 214 267 288
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
24.73 22.29 19.52 18.83 35.82 30.52 39.26 33.40 47.64 55.18 33.18
Price to Tangible Book Value (P/TBV)
36.28 35.24 30.30 32.62 63.67 42.66 52.23 46.03 61.36 69.67 41.36
Price to Revenue (P/Rev)
8.69 6.24 5.74 4.95 8.25 11.40 14.83 9.88 14.27 15.83 9.66
Price to Earnings (P/E)
46.72 30.39 29.32 26.46 59.42 76.59 89.07 58.74 75.08 75.58 47.48
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.14% 3.29% 3.41% 3.78% 1.68% 1.31% 1.12% 1.70% 1.33% 1.32% 2.11%
Enterprise Value to Invested Capital (EV/IC)
70.52 49.89 66.54 57.31 157.77 456.38 0.00 5,497.02 1,722.90 493.64 0.00
Enterprise Value to Revenue (EV/Rev)
8.46 6.09 5.53 4.77 8.07 11.05 14.43 9.58 13.98 15.58 9.35
Enterprise Value to EBITDA (EV/EBITDA)
27.80 18.03 17.07 18.57 40.42 52.82 67.48 44.76 60.65 60.80 35.14
Enterprise Value to EBIT (EV/EBIT)
29.14 18.87 17.91 19.75 43.22 56.98 71.46 46.66 62.32 62.27 35.93
Enterprise Value to NOPAT (EV/NOPAT)
45.87 29.89 28.12 25.95 58.21 74.06 86.51 59.01 74.87 75.85 46.99
Enterprise Value to Operating Cash Flow (EV/OCF)
39.17 26.41 20.05 19.44 33.94 45.97 51.71 40.91 52.74 55.05 25.97
Enterprise Value to Free Cash Flow (EV/FCFF)
50.36 31.70 23.28 25.25 49.54 61.76 69.42 66.73 77.65 86.04 38.59
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.67 -0.62 -0.64 -0.70 -0.73 -0.87 -1.00 -1.02 -0.98 -0.93 -0.97
Leverage Ratio
1.72 1.73 1.78 1.93 2.35 2.32 2.14 2.32 2.46 2.48 2.60
Compound Leverage Factor
1.74 1.74 1.79 1.95 2.36 2.32 2.14 2.33 2.52 2.54 2.64
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
25.76 23.16 19.67 14.68 16.74 19.39 23.53 16.33 23.37 24.89 15.10
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.86 1.76 1.84 1.48 1.28 1.70 1.64 1.32 1.31 1.26 1.28
Quick Ratio
1.78 1.67 1.75 1.38 1.17 1.59 1.56 1.24 1.24 1.18 1.19
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
93 116 141 106 101 105 138 110 167 189 262
Operating Cash Flow to CapEx
1,045.54% 2,036.33% 2,646.65% 1,879.95% 966.95% 5,160.62% 4,611.13% 2,727.04% 5,205.45% 3,400.61% 2,519.70%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.71 1.92 1.94 1.80 1.82 1.40 1.32 1.38 1.49 1.46 1.35
Accounts Receivable Turnover
6.04 6.12 6.18 5.81 6.15 5.58 5.68 5.27 5.34 5.39 5.15
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
28.95 31.32 36.13 37.51 33.36 28.87 41.75 57.48 75.51 80.91 58.31
Accounts Payable Turnover
19.87 21.48 18.84 14.96 14.71 0.00 15.91 15.81 17.15 18.43 19.36
Days Sales Outstanding (DSO)
60.42 59.67 59.09 62.78 59.38 65.40 64.25 69.28 68.37 67.70 70.91
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
18.37 17.00 19.37 24.40 24.81 0.00 22.94 23.09 21.28 19.81 18.85
Cash Conversion Cycle (CCC)
42.05 42.67 39.72 38.37 34.56 65.40 41.31 46.19 47.09 47.89 52.05
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
67 74 49 47 32 14 -13 1.34 7.54 33 -14
Invested Capital Turnover
8.95 8.61 9.65 11.65 15.81 25.61 1,174.59 -130.85 209.31 51.56 114.35
Increase / (Decrease) in Invested Capital
9.15 7.02 -24 -2.85 -15 -17 -27 14 6.20 25 -47
Enterprise Value (EV)
4,706 3,680 3,289 2,670 4,985 6,477 9,576 7,350 12,985 16,239 10,115
Market Capitalization
4,835 3,775 3,415 2,770 5,096 6,682 9,840 7,575 13,256 16,505 10,443
Book Value per Share
$2.68 $2.38 $2.54 $2.25 $2.23 $3.45 $3.96 $3.63 $4.52 $4.90 $5.22
Tangible Book Value per Share
$1.82 $1.51 $1.64 $1.30 $1.25 $2.47 $2.98 $2.64 $3.51 $3.88 $4.19
Total Capital
195 169 175 147 142 219 251 227 278 299 315
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-129 -96 -126 -101 -111 -205 -264 -225 -271 -266 -329
Capital Expenditures (CapEx)
11 6.84 6.20 7.31 15 2.73 4.02 6.59 4.73 8.68 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-19 -6.24 -22 -30 -60 -68 -104 -126 -157 -163 -201
Debt-free Net Working Capital (DFNWC)
110 89 104 70 50 137 159 100 113 103 127
Net Working Capital (NWC)
110 89 104 70 50 137 159 100 113 103 127
Net Nonoperating Expense (NNE)
-0.89 -1.14 0.51 -1.80 -0.11 0.22 0.22 -4.42 -3.13 -4.27 -4.69
Net Nonoperating Obligations (NNO)
-129 -96 -126 -101 -111 -205 -264 -225 -271 -266 -329
Total Depreciation and Amortization (D&A)
7.76 9.09 9.06 8.61 7.99 8.95 7.91 6.66 5.75 6.30 6.32
Debt-free, Cash-free Net Working Capital to Revenue
-3.42% -1.03% -3.65% -5.45% -9.75% -11.54% -15.72% -16.38% -16.96% -15.66% -18.62%
Debt-free Net Working Capital to Revenue
19.72% 14.78% 17.46% 12.54% 8.16% 23.37% 24.02% 13.01% 12.20% 9.88% 11.78%
Net Working Capital to Revenue
19.72% 14.78% 17.46% 12.54% 8.16% 23.37% 24.02% 13.01% 12.20% 9.88% 11.78%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.41 $1.73 $1.68 $1.58 $1.33 $1.37 $1.74 $2.05 $0.00 $3.56 $3.64
Adjusted Weighted Average Basic Shares Outstanding
73.44M 71.67M 69.18M 66.20M 64.40M 63.54M 63.45M 62.77M 0.00 61.30M 60.47M
Adjusted Diluted Earnings per Share
$1.40 $1.72 $1.68 $1.58 $1.32 $1.36 $1.72 $2.03 $0.00 $3.51 $3.60
Adjusted Weighted Average Diluted Shares Outstanding
74.04M 72.06M 69.42M 66.43M 65.10M 64.33M 64.32M 63.41M 0.00 62.18M 61.05M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
73.00M 70.40M 67.97M 65.02M 63.77M 63.80M 63.15M 62.50M 0.00 61.12M 59.85M
Normalized Net Operating Profit after Tax (NOPAT)
103 123 119 103 86 87 111 125 173 214 218
Normalized NOPAT Margin
18.44% 20.36% 19.99% 18.40% 13.86% 14.92% 16.68% 16.24% 18.67% 20.54% 20.11%
Pre Tax Income Margin
29.27% 32.44% 31.09% 24.36% 18.78% 19.40% 20.20% 20.61% 23.01% 25.60% 26.44%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
108.37% 135.17% 113.07% 142.63% 141.66% 49.93% 109.00% 158.55% 111.03% 131.14% 143.29%

Quarterly Metrics And Ratios for Manhattan Associates

This table displays calculated financial ratios and metrics derived from Manhattan Associates' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 59,847,548.00 59,164,602.00 58,304,972.00
DEI Adjusted Shares Outstanding
- - - - - - - - 59,847,548.00 59,164,602.00 58,304,972.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.82 0.85 1.05
Growth Metrics
- - - - - - - - - - -
Revenue Growth
15.18% 14.85% 11.84% 7.36% 3.24% 2.68% 3.42% 5.70% 7.39% 9.31% 11.02%
EBITDA Growth
23.41% 33.58% 37.90% 4.21% 9.87% 7.79% 2.56% 12.54% 7.66% -9.52% 5.63%
EBIT Growth
24.13% 34.12% 38.44% 4.09% 10.03% 7.82% 2.66% 13.07% 7.39% -9.78% 5.68%
NOPAT Growth
36.75% 34.13% 30.97% -3.21% -2.64% 8.00% -9.57% 9.41% -10.26% -11.77% 5.75%
Net Income Growth
38.69% 33.18% 29.06% -1.48% -2.27% 7.61% -8.07% 8.20% -6.25% -11.32% 4.62%
EPS Growth
38.71% 34.92% 30.38% -1.28% -1.16% 9.41% -6.80% 11.69% -3.53% -8.60% 8.33%
Operating Cash Flow Growth
-6.78% 80.58% 6.36% 18.50% 37.49% 1.08% 49.46% 40.44% 11.67% 22.46% -26.34%
Free Cash Flow Firm Growth
-49.32% -11.44% 29.93% -49.49% 118.69% 46.44% 169.38% 362.61% 139.87% 174.81% 40.92%
Invested Capital Growth
6,234.42% 119.75% 126.67% 336.46% 22.25% 27.02% -27.52% -142.50% -153.43% -159.38% -97.17%
Revenue Q/Q Growth
0.00% 4.23% 0.51% -4.08% 2.73% 3.67% 1.24% -1.96% 4.37% 5.52% 2.82%
EBITDA Q/Q Growth
0.00% 17.42% 10.62% -25.36% 13.32% 15.20% 5.26% -18.10% 8.41% -3.18% 22.88%
EBIT Q/Q Growth
0.00% 17.87% 10.56% -25.85% 13.86% 15.49% 5.27% -18.32% 8.14% -2.97% 23.31%
NOPAT Q/Q Growth
0.00% -1.55% 20.39% -25.84% 10.77% 9.21% 0.80% -10.28% -9.15% 7.37% 20.82%
Net Income Q/Q Growth
0.00% -1.92% 20.88% -24.72% 9.51% 7.98% 3.26% -11.39% -5.12% 2.14% 21.83%
EPS Q/Q Growth
0.00% -1.16% 21.18% -25.24% 10.39% 9.41% 3.23% -10.42% -4.65% 3.66% 22.35%
Operating Cash Flow Q/Q Growth
0.00% 33.84% -14.96% 68.07% -28.12% -1.61% 25.74% 57.93% -42.85% 7.89% -24.36%
Free Cash Flow Firm Q/Q Growth
0.00% 54.85% -12.50% -23.11% 109.93% 3.69% 60.96% 32.04% 8.85% 18.80% -17.46%
Invested Capital Q/Q Growth
0.00% 18.19% 66.14% -47.78% 19.23% 22.80% -5.20% -130.62% -49.89% -36.48% 104.52%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 54.76% 55.50% 9.20% 56.40% 100.00% 56.56% 54.97% 55.13% 56.53% 56.93%
EBITDA Margin
23.62% 26.61% 29.28% 22.79% 25.13% 27.93% 29.04% 24.26% 25.20% 23.12% 27.63%
Operating Margin
22.64% 25.70% 28.16% 23.72% 24.04% 27.09% 27.49% 24.78% 23.01% 22.24% 26.45%
EBIT Margin
23.03% 26.05% 28.65% 22.15% 24.55% 27.35% 28.44% 23.69% 24.55% 22.57% 27.07%
Profit (Net Income) Margin
21.14% 19.89% 23.92% 18.77% 20.01% 20.84% 21.26% 19.21% 17.47% 16.91% 20.03%
Tax Burden Percent
91.77% 76.36% 83.48% 76.60% 81.51% 76.21% 74.76% 75.90% 71.16% 74.91% 74.01%
Interest Burden Percent
100.00% 100.00% 100.00% 110.64% 100.00% 100.00% 100.00% 106.85% 100.00% 100.00% 100.00%
Effective Tax Rate
8.23% 23.64% 16.52% 23.40% 18.49% 23.79% 25.24% 24.10% 28.84% 25.09% 25.99%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 937.00% 577.40% 507.25% 403.59% 2,150.95% 1,973.76% 1,918.27% 964.50%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 936.43% 576.88% 507.00% 402.77% 2,150.58% 1,972.33% 1,917.92% 963.90%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% -870.85% -492.01% -422.97% -328.24% -2,084.32% -1,892.33% -1,831.91% -875.15%
Return on Equity (ROE)
0.00% 0.00% 0.00% 66.14% 85.39% 84.28% 75.35% 66.63% 81.43% 86.36% 89.36%
Cash Return on Invested Capital (CROIC)
-101.63% -74.90% -77.55% 933.57% 576.62% 480.10% 420.06% 0.00% 0.00% 0.00% 1,068.74%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 32.27% 37.30% 41.03% 41.36% 32.09% 37.30% 35.22% 41.20%
Return on Assets (ROA)
0.00% 0.00% 0.00% 27.35% 30.40% 31.27% 30.92% 26.02% 26.54% 26.39% 30.50%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 66.14% 85.39% 84.28% 75.35% 66.63% 81.43% 86.36% 89.36%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 88.60% 79.34% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
53 52 63 46 51 56 57 51 46 50 60
NOPAT Margin
20.78% 19.62% 23.51% 18.17% 19.59% 20.64% 20.55% 18.81% 16.37% 16.66% 19.58%
Net Nonoperating Expense Percent (NNEP)
0.47% 0.39% 0.55% 0.57% 0.53% 0.25% 0.81% 0.37% 1.43% 0.35% 0.60%
Return On Investment Capital (ROIC_SIMPLE)
- - - 15.54% 21.01% 20.17% 18.33% 16.16% 22.52% 31.50% 29.86%
Cost of Revenue to Revenue
0.00% 45.24% 44.50% 90.80% 43.60% 0.00% 43.44% 45.03% 44.87% 43.47% 43.08%
SG&A Expenses to Revenue
8.33% 7.96% 7.62% 10.63% 9.22% 9.54% 8.73% 7.21% 8.40% 8.98% 9.56%
R&D to Revenue
13.75% 13.32% 12.88% 12.90% 13.43% 12.80% 13.18% 14.25% 13.23% 11.67% 11.61%
Operating Expenses to Revenue
77.36% 29.06% 27.35% -14.53% 32.36% 72.91% 29.06% 30.19% 32.12% 34.29% 30.47%
Earnings before Interest and Taxes (EBIT)
59 69 76 57 65 75 78 64 69 67 83
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
60 71 78 58 66 76 80 66 71 69 85
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
64.29 63.12 62.00 55.18 43.15 43.01 40.08 33.18 38.83 52.31 57.71
Price to Tangible Book Value (P/TBV)
86.85 85.14 79.89 69.67 57.84 55.37 50.19 41.36 55.74 86.48 83.65
Price to Revenue (P/Rev)
0.00 0.00 0.00 15.83 10.07 11.34 11.62 9.66 7.24 7.32 10.02
Price to Earnings (P/E)
0.00 0.00 0.00 75.58 48.71 54.21 57.38 47.48 36.77 39.19 54.40
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 1.32% 2.05% 1.84% 1.74% 2.11% 2.72% 2.55% 1.84%
Enterprise Value to Invested Capital (EV/IC)
473.71 395.18 270.14 493.64 264.42 244.13 265.68 0.00 0.00 0.00 8,798.88
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 15.58 9.87 11.12 11.37 9.35 7.03 7.15 9.84
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 60.80 37.99 42.22 43.25 35.14 26.43 28.19 39.24
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 62.27 38.89 43.22 44.26 35.93 27.04 28.86 40.17
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 75.85 48.75 54.21 57.53 46.99 36.88 39.61 55.12
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 55.05 32.87 37.17 34.95 25.97 19.44 19.41 29.17
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 86.04 50.45 56.90 53.16 38.59 28.66 28.75 45.38
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.93 -0.87 -0.81 -0.93 -0.85 -0.83 -0.81 -0.97 -0.96 -0.96 -0.91
Leverage Ratio
2.87 2.90 2.60 2.48 2.85 2.71 2.50 2.60 3.22 3.31 2.98
Compound Leverage Factor
2.87 2.90 2.60 2.74 2.85 2.71 2.50 2.78 3.22 3.31 2.98
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
22.21 22.48 25.73 24.00 16.11 17.89 18.72 14.24 11.26 11.44 15.04
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.20 1.17 1.25 1.26 1.12 1.19 1.31 1.28 1.10 0.98 1.07
Quick Ratio
1.11 1.09 1.14 1.18 1.03 1.08 1.21 1.19 0.97 0.85 0.97
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
20 31 27 21 44 46 74 98 106 126 104
Operating Cash Flow to CapEx
2,358.38% 3,304.56% 6,174.33% 3,347.31% 8,446.69% 1,860.55% 1,570.68% 3,156.93% 2,048.38% 9,022.89% 6,921.19%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 1.46 1.52 1.50 1.45 1.35 1.52 1.56 1.52
Accounts Receivable Turnover
0.00 0.00 0.00 5.39 5.05 5.27 5.09 5.15 5.03 5.25 4.74
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 80.91 80.22 72.01 64.93 58.31 56.78 55.49 52.72
Accounts Payable Turnover
0.00 0.00 0.00 18.43 18.43 13.99 20.93 19.36 20.78 18.22 23.45
Days Sales Outstanding (DSO)
0.00 0.00 0.00 67.70 72.33 69.20 71.73 70.91 72.58 69.47 76.95
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 19.81 19.81 26.08 17.44 18.85 17.56 20.03 15.56
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 47.89 52.53 43.12 54.29 52.05 55.02 49.44 61.39
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
32 38 63 33 39 48 46 -14 -21 -29 1.29
Invested Capital Turnover
0.00 0.00 0.00 51.56 29.47 24.57 19.64 114.35 120.55 115.14 49.26
Increase / (Decrease) in Invested Capital
33 21 35 25 7.14 10 -17 -47 -60 -77 -44
Enterprise Value (EV)
15,198 14,985 17,018 16,239 10,371 11,759 12,131 10,115 7,741 8,053 11,386
Market Capitalization
15,405 15,188 17,233 16,505 10,577 11,989 12,395 10,443 7,967 8,239 11,585
Book Value per Share
$3.89 $3.91 $4.54 $4.90 $4.01 $4.59 $5.11 $5.22 $3.43 $2.66 $3.44
Tangible Book Value per Share
$2.88 $2.90 $3.52 $3.88 $2.99 $3.57 $4.08 $4.19 $2.39 $1.61 $2.38
Total Capital
240 241 278 299 245 279 309 315 205 158 201
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-208 -203 -215 -266 -206 -231 -264 -329 -226 -186 -199
Capital Expenditures (CapEx)
2.32 2.22 1.01 3.13 0.89 3.98 5.93 4.66 4.10 1.01 0.99
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-134 -139 -125 -163 -156 -154 -138 -201 -178 -194 -167
Debt-free Net Working Capital (DFNWC)
73 63 90 103 50 76 125 127 48 -7.99 33
Net Working Capital (NWC)
73 63 90 103 50 76 125 127 48 -7.99 33
Net Nonoperating Expense (NNE)
-0.91 -0.70 -1.10 -1.53 -1.09 -0.54 -1.95 -1.09 -3.09 -0.74 -1.40
Net Nonoperating Obligations (NNO)
-208 -203 -215 -266 -206 -231 -264 -329 -226 -186 -199
Total Depreciation and Amortization (D&A)
1.49 1.49 1.69 1.63 1.54 1.58 1.66 1.53 1.83 1.63 1.72
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% -15.66% -14.81% -14.60% -12.95% -18.62% -16.14% -17.24% -14.41%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 9.88% 4.79% 7.20% 11.75% 11.78% 4.40% -0.71% 2.84%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 9.88% 4.79% 7.20% 11.75% 11.78% 4.40% -0.71% 2.84%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.87 $0.86 $1.04 $0.79 $0.86 $0.94 $0.97 $0.87 $0.83 $0.86 $1.05
Adjusted Weighted Average Basic Shares Outstanding
61.63M 61.42M 61.17M 61.30M 60.87M 60.61M 60.38M 60.47M 59.69M 58.76M 58.21M
Adjusted Diluted Earnings per Share
$0.86 $0.85 $1.03 $0.77 $0.85 $0.93 $0.96 $0.86 $0.82 $0.85 $1.04
Adjusted Weighted Average Diluted Shares Outstanding
62.49M 62.12M 61.95M 62.18M 61.53M 61.07M 60.95M 61.05M 60.04M 59.00M 58.73M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
61.57M 61.25M 61.08M 61.12M 60.71M 60.47M 60.26M 59.85M 59.16M 58.30M 58.06M
Normalized Net Operating Profit after Tax (NOPAT)
53 52 63 46 54 56 57 51 46 56 60
Normalized NOPAT Margin
20.78% 19.62% 23.51% 18.17% 20.50% 20.65% 20.55% 18.81% 16.37% 18.74% 19.58%
Pre Tax Income Margin
23.03% 26.05% 28.65% 24.51% 24.55% 27.35% 28.44% 25.32% 24.55% 22.57% 27.07%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 131.14% 142.29% 128.17% 131.20% 143.29% 165.28% 206.91% 203.76%

Financials Breakdown Chart

Key Financial Trends

Manhattan Associates (NASDAQ: MANH) continues to show strong long-term revenue growth, but its latest results point to margin pressure and an increasingly aggressive capital-return strategy. Revenue reached $297.8 million in Q2 2026, up 9.3% from $272.4 million in Q2 2025 and roughly 50% above Q3 2022 levels.

Profitability remains solid in absolute terms, with Q2 2026 operating income of $66.2 million and net income of $50.4 million. However, net income declined from $56.8 million a year earlier, while diluted EPS fell to $0.85 from $0.93. The operating margin also compressed to approximately 22.2%, compared with 27.1% in Q2 2025, as operating expenses increased and the company recorded an $8.3 million restructuring charge.

Cash generation remains a major strength. Operating cash flow increased to $90.7 million in Q2 2026, well above $73.3 million in the prior-year quarter, while capital expenditures were only $1.0 million. Nevertheless, large share repurchases reduced cash and shareholders’ equity. Cash declined to $186.1 million from $226.1 million at the end of Q1, following $127.1 million of buybacks during the quarter.

  • Sustained revenue expansion: Quarterly revenue has risen from approximately $198.1 million in Q3 2022 to $297.8 million in Q2 2026, indicating a durable growth trend.
  • Strong operating cash flow: Q2 2026 operating cash flow increased nearly 24% year over year to $90.7 million, providing substantial funding for reinvestment and shareholder returns.
  • Low capital intensity: Capital expenditures were just $1.0 million in Q2 2026, leaving estimated operating cash flow after capital expenditures near $89.7 million.
  • Share-count reduction: Diluted shares outstanding declined to 59.0 million in Q2 2026 from 61.1 million in Q2 2025, helping support per-share results over time.
  • No conventional debt is reported: The balance sheet lists no meaningful debt category, limiting interest-rate and refinancing risk.
  • Deferred revenue remains substantial: Current deferred revenue was $343.2 million, representing a large source of future revenue recognition and an important liability investors should monitor.
  • Margin compression: Q2 2026 operating margin fell to roughly 22.2% from about 27.1% in the comparable quarter, despite higher revenue.
  • Net income and EPS declined year over year: Net income fell approximately 11% and diluted EPS dropped about 9% from Q2 2025.
  • Rising operating expenses: Selling, general and administrative, marketing, and restructuring costs were higher than in Q2 2025, while research and development spending remained elevated.
  • Aggressive buybacks are reducing liquidity: Manhattan Associates repurchased $127.1 million of stock in Q2 and $306.5 million during the first half of 2026, contributing to lower cash, lower equity, and a current ratio below 1.0.

Overall, the statements show a financially productive software business with strong revenue momentum and cash conversion. The main issue for investors is whether Manhattan Associates can convert that growth into improving margins while continuing its sizable buyback program. The sharp decline in equity and cash balances makes future capital allocation and operating-margin trends particularly important.

11/17/26 12:04 AM ETAI Generated. May Contain Errors.

Manhattan Associates Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Manhattan Associates' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Manhattan Associates' net income appears to be on an upward trend, with a most recent value of $219.95 million in 2025, rising from $103.48 million in 2015. The previous period was $218.36 million in 2024. Find out what analysts predict for Manhattan Associates in the coming months.

Manhattan Associates' total operating income in 2025 was $279.80 million, based on the following breakdown:
  • Total Gross Profit: $609.05 million
  • Total Operating Expenses: $329.25 million

Over the last 10 years, Manhattan Associates' total revenue changed from $556.37 million in 2015 to $1.08 billion in 2025, a change of 94.4%.

In the past 13 quarters, Manhattan Associates' cash and equivalents has ranged from $153.29 million in Q2 2023 to $263.56 million in Q3 2025, and is currently $199.45 million as of their latest financial filing in Q3 2026.

Manhattan Associates had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2015.

Over the last 10 years, Manhattan Associates' book value per share changed from 2.68 in 2015 to 5.22 in 2025, a change of 95.2%.



Financial statements for NASDAQ:MANH last updated on 10/30/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners